Conclusions:
Our finding that
resistance to trabectedin is associated with the loss of NER function,
with a consequent increased sensitivity to platinum drugs, provides the
rational for sequential use of these drugs in patients who have acquired
resistance to trabectedin.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.